SK284601B6 - Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS - Google Patents

Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS Download PDF

Info

Publication number
SK284601B6
SK284601B6 SK586-98A SK58698A SK284601B6 SK 284601 B6 SK284601 B6 SK 284601B6 SK 58698 A SK58698 A SK 58698A SK 284601 B6 SK284601 B6 SK 284601B6
Authority
SK
Slovakia
Prior art keywords
flupirtine
cells
hiv
apoptosis
infected
Prior art date
Application number
SK586-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK58698A3 (en
Inventor
Gabriela Pergande
Werner E. G. M�Ller
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of SK58698A3 publication Critical patent/SK58698A3/sk
Publication of SK284601B6 publication Critical patent/SK284601B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK586-98A 1995-11-07 1996-10-23 Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS SK284601B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19541405A DE19541405A1 (de) 1995-11-07 1995-11-07 Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
PCT/DE1996/002009 WO1997017072A2 (de) 1995-11-07 1996-10-23 Verwendung von flupirtin zur prophylaxe und therapie von erkrankungen, die mit einer beeinträchtigung des hämatopoetischen zellsystems einhergehen

Publications (2)

Publication Number Publication Date
SK58698A3 SK58698A3 (en) 1998-09-09
SK284601B6 true SK284601B6 (sk) 2005-07-01

Family

ID=7776799

Family Applications (1)

Application Number Title Priority Date Filing Date
SK586-98A SK284601B6 (sk) 1995-11-07 1996-10-23 Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS

Country Status (27)

Country Link
US (2) US6034111A (no)
EP (1) EP0859613B1 (no)
JP (1) JPH11514652A (no)
KR (1) KR100512673B1 (no)
CN (1) CN1116037C (no)
AT (1) ATE316789T1 (no)
AU (1) AU711207B2 (no)
BG (1) BG63149B1 (no)
BR (1) BR9611588A (no)
CA (1) CA2189705C (no)
CZ (1) CZ298115B6 (no)
DE (2) DE19541405A1 (no)
DK (1) DK0859613T3 (no)
ES (1) ES2257755T3 (no)
HK (1) HK1016508A1 (no)
HU (1) HU225742B1 (no)
MX (1) MX9803610A (no)
NO (1) NO315074B1 (no)
NZ (1) NZ330414A (no)
PL (1) PL186537B1 (no)
PT (1) PT859613E (no)
RU (1) RU2200555C2 (no)
SK (1) SK284601B6 (no)
TW (1) TW393317B (no)
UA (1) UA51682C2 (no)
WO (1) WO1997017072A2 (no)
ZA (1) ZA968783B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
EP1688141A1 (en) * 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
AU2010279452B2 (en) * 2009-08-07 2015-04-30 Swagelok Company Low temperature carburization under soft vacuum
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
BR112014021433A2 (pt) * 2012-03-02 2017-07-18 Meda Pharma Gmbh & Co Kg formulações farmacêuticas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172468B (no) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

Also Published As

Publication number Publication date
HK1016508A1 (en) 1999-11-05
HUP9901659A2 (hu) 1999-09-28
CZ298115B6 (cs) 2007-06-27
TW393317B (en) 2000-06-11
DE19541405A1 (de) 1997-05-15
HUP9901659A3 (en) 2001-04-28
PL326629A1 (en) 1998-10-12
EP0859613A2 (de) 1998-08-26
NO981898L (no) 1998-04-27
ES2257755T3 (es) 2006-08-01
HU225742B1 (en) 2007-07-30
PT859613E (pt) 2006-06-30
DK0859613T3 (da) 2006-06-06
WO1997017072A2 (de) 1997-05-15
CA2189705C (en) 2005-08-09
BG102404A (en) 1998-12-30
NO981898D0 (no) 1998-04-27
DE59611327D1 (de) 2006-04-13
CN1116037C (zh) 2003-07-30
NO315074B1 (no) 2003-07-07
UA51682C2 (uk) 2002-12-16
CA2189705A1 (en) 1997-05-08
MX9803610A (es) 1998-09-30
AU1716597A (en) 1997-05-29
ZA968783B (en) 1997-05-27
CZ128398A3 (cs) 1998-09-16
WO1997017072A3 (de) 1997-07-24
PL186537B1 (pl) 2004-01-30
KR19990067366A (ko) 1999-08-16
SK58698A3 (en) 1998-09-09
KR100512673B1 (ko) 2005-12-09
JPH11514652A (ja) 1999-12-14
RU2200555C2 (ru) 2003-03-20
ATE316789T1 (de) 2006-02-15
CN1201391A (zh) 1998-12-09
EP0859613B1 (de) 2006-02-01
BR9611588A (pt) 1999-04-06
AU711207B2 (en) 1999-10-07
US6034111A (en) 2000-03-07
NZ330414A (en) 1999-10-28
US6034112A (en) 2000-03-07
BG63149B1 (bg) 2001-05-31

Similar Documents

Publication Publication Date Title
SK154796A3 (en) Use of rapamycin for the inhibition of neuronal cells necrosis
Crowe Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection
SK284601B6 (sk) Použitie flurpirtinu na prípravu liečiva na liečenie HIV alebo AIDS
JPH07173063A (ja) 製薬学的に活性な化合物を含有するマラリヤの治療剤
CA1261272A (en) Dihydropyridine combination product
WO1997017072A9 (de) Verwendung von flupirtin zur prophylaxe und therapie von erkrankungen, die mit einer beeinträchtigung des hämatopoetischen zellsystems einhergehen
SK24098A3 (en) Combinatory composition for the treatment of dementia
Baek et al. Induction of apoptosis by bile acids in HepG2 human hepatocellular carcinoma cells
SK50696A3 (en) Flavin and its derivatives as anti-viral agents
JPH0521891B2 (no)
JPH01233226A (ja) 抗ウイルス薬剤の製造への乳蛋白の利用
EP1075270B1 (en) Short peptide for treatment of neurological degenerative diseases
Rosengarten et al. A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats
EP0476391B1 (en) Anti-AIDS virus composition containing cepharanthine as active compound
US20020198247A1 (en) Pharmaceutical composition for inhibiting the growth of viruses and cancers
Müller et al. Flupirtine protects both neuronal cells and lymphocytes against induced apoptosis in vitro: implications for treatment of AIDS patients
EP0555302A1 (en) Method of treating demyelinating disease
CA2064112C (en) .alpha.-dihydroergocryptine pharmaceutical preparations with neuroprotective activity
WO1993025203A1 (en) Method of treating and protecting against central nervous system ischemia, hypoxia, degeneration, and trauma with a 5-aminocarbonyl-sh-dibenzo[a,d]cyclohepten-5,10-imine
Dearsly et al. Sexual development in Plasmodium berghei: the use of mitomycin C to separate infective gametocytes in vivo and ookinetes in vitro
NZ242264A (en) Polyadenylic acid/polyuridylic acid complexes in pharmaceutical compositions
HUT58523A (en) Process for producing antiviral compositions from modified gangliosides
CA2251800A1 (en) Nitrone free radical trap treatment of dementia associated with aids virus (hiv-1) infection

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20131023